Disclosure: This site earns commissions from affiliate links (Amazon, Etsy, and others) at no extra cost to you.   Full affiliate disclosure →

Updated July 2026 · 8 min read

This article was created with AI assistance.

Carcinoid Crisis for ICU Nurses 2026 — The Tumor Storm Where the Usual Pressors Backfire

⚕️ Medical Disclaimer: This content is for educational purposes only and is intended for licensed healthcare professionals. It does not constitute medical advice and should not replace clinical judgment, facility protocols, or physician orders. Always verify medications, doses, and procedures with your institution's guidelines.

Part of the ICU Emergencies Hub — browse every related guide in one place.

A patient with a known neuroendocrine tumor is booked for surgery or a procedure, and partway through they suddenly flush deep red, their blood pressure swings wildly, and they start to wheeze. The instinct is to reach for the usual rescue — a catecholamine to prop up the pressure — but in this patient that reflex can pour fuel on the fire. This is carcinoid crisis: a sudden, massive release of vasoactive hormones from a carcinoid tumor, and it is one of the few emergencies where the standard pressor can make things worse and where the right drug is one many nurses rarely hang. Knowing the pattern, and knowing the trap, is what makes the ICU nurse an asset when a carcinoid patient tips over.

The short version: Carcinoid crisis is a life-threatening surge of tumor-released mediators (serotonin and others) from a neuroendocrine (carcinoid) tumor, often triggered by surgery, anesthesia, tumor manipulation, or procedures. It presents with intense flushing, severe blood-pressure swings (usually profound hypotension, sometimes hypertension), bronchospasm/wheezing, and tachyarrhythmias. The treatment is octreotide (a somatostatin analog that shuts off mediator release), plus careful supportive care. The key trap: catecholamine vasopressors can paradoxically worsen the crisis by stimulating more mediator release, so hypotension is managed with octreotide and fluids first.

Why a tumor causes a whole-body storm

Carcinoid tumors are neuroendocrine tumors, most often arising in the gut or lungs, that secrete a cocktail of vasoactive substances — serotonin chief among them, along with others. In everyday life, a patient with these tumors may have the chronic "carcinoid syndrome" of episodic flushing and diarrhea. A carcinoid crisis is the extreme, acute version: the tumor dumps a massive bolus of mediators into the circulation all at once. Those mediators act all over the body simultaneously — dilating and constricting vessels, tightening the airways, and irritating the heart — which is why the picture is a chaotic mix of flushing, blood-pressure extremes, wheezing, and arrhythmia rather than a single organ problem. The classic triggers are anything that squeezes or stresses the tumor: induction of anesthesia, surgery, physical manipulation of the tumor during an operation, and some procedures. That predictability is a gift, because it means the crisis can often be prevented or blunted before it starts.

Recognizing the crisis at the bedside

FeatureWhat the nurse sees
FlushingSudden, intense redness of the face/upper body — often the first sign
Blood pressure instabilityProfound hypotension is typical; some patients swing hypertensive; both can occur
BronchospasmWheezing, rising airway pressures on the ventilator, hypoxia
Arrhythmias / tachycardiaMediator effect on the heart
SettingKnown carcinoid/neuroendocrine tumor, usually around surgery, anesthesia, or a procedure

The combination that names the diagnosis is flushing plus hemodynamic and airway chaos in a patient with a known neuroendocrine tumor around the time of a procedure. Because the swings can be severe and rapid, the crisis is managed in real time with continuous monitoring, and the nurse's early recognition — "this is the tumor, not simple anesthesia hypotension" — steers the team toward octreotide rather than reflexive escalation of catecholamines.

The pressor trap

Reaching for a catecholamine can make it worse. In carcinoid crisis, adrenergic vasopressors (like epinephrine) can stimulate the tumor to release more mediators, potentially deepening the very hypotension you are trying to treat. This is the counterintuitive point that catches teams off guard: the low blood pressure of a carcinoid crisis is managed first with octreotide and fluids, not by climbing a standard pressor. If vasopressor support is truly needed, it is chosen and titrated with this risk in mind and with the crisis being suppressed by octreotide at the same time. When a known-carcinoid patient becomes hypotensive around surgery, the nurse who says "before we chase this with epi, is this a carcinoid crisis that needs octreotide?" is protecting the patient.

Octreotide: the drug that shuts off the storm

The specific treatment is octreotide, a somatostatin analog that blocks the tumor's release of its mediators — effectively turning off the tap that is driving the whole crisis. It is given as boluses and often an infusion, titrated to control the flushing, blood pressure, and bronchospasm. Because carcinoid crisis is so predictable around surgery, patients with known tumors are frequently given octreotide prophylactically before and during high-risk procedures to prevent the crisis in the first place, and having octreotide immediately available is part of safe planning. For the nurse, that means knowing where the octreotide is, being ready to give it quickly, and understanding that it — not the usual code-cart pressor — is the front-line answer to a carcinoid patient's sudden collapse.

Supportive nursing care around the octreotide

Alongside octreotide, the care is attentive support of a patient whose hemodynamics and airway are swinging. Give fluids to support the blood pressure, manage the bronchospasm and oxygenation (rising ventilator airway pressures are a clue), watch the rhythm for the tachyarrhythmias these mediators provoke, and monitor closely and continuously because the picture can change minute to minute. Support the airway and breathing as needed, keep large-bore access, and communicate clearly with anesthesia and the surgical team, who may pause tumor manipulation until the crisis is controlled. As the octreotide takes hold, the flushing settles, the pressure stabilizes, and the wheezing eases — the reassurance that the crisis is being controlled at its source rather than merely chased at the periphery.

The nursing bottom line

Carcinoid crisis is a neuroendocrine tumor emptying its vasoactive contents into the bloodstream all at once, usually triggered by surgery or a procedure, and producing a whole-body storm of flushing, blood-pressure extremes, bronchospasm, and arrhythmia. The two things every ICU nurse should carry are the recognition — flushing plus hemodynamic and airway chaos in a known-carcinoid patient around a procedure — and the trap: reflexive catecholamine pressors can worsen it, so the low pressure is treated first with octreotide and fluids. Octreotide is the drug that shuts the storm off at the tumor, it is often given prophylactically before high-risk surgery, and it belongs within reach for these patients. Recognize the pattern, resist the reflex, reach for the octreotide, and support the swinging physiology, and you carry a carcinoid patient safely through a crisis that ambushes teams who do not know it.

Related: Serotonin syndrome · Octreotide in sulfonylurea overdose · Acid-base balance

Educational content for licensed clinicians. Always follow your facility's protocol and provider orders. Not medical advice.

Get The ICU Notebook Newsletter

Clinical tools and career insights for ICU nurses. One email per week, no fluff.

Yes, send it free

No spam. Unsubscribe any time.